サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439426

核医学イメージング装置 - 世界市場の考察、競合情勢、市場予測（2030年）

Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
核医学イメージング装置 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核医学イメージング装置の市場規模は、2023年に25億7,000万米ドル、2030年までに31億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで3.34％の成長が見込まれます。市場は、心血管疾患の有病率の上昇、がんの有病率の増加、老年人口の増加、製品提供における技術の進歩などの要因により、プラス成長を示しています。したがって、上記のこれらすべての要因が、2024年～2030年の予測期間における市場成長に寄与します。

核医学イメージング装置の市場力学

核医学イメージング装置市場の主な促進要因の1つは、心血管疾患の有病率の増加です。2022年に発表された世界保健機関（WHO）のデータによると、最新の統計では、心血管疾患（CVD）は世界でもっとも一般的な死因となっています。上述の資料によると、2019年に1,790万人がCVDで死亡し、全世界の死亡者数の32％を占め、その85％が心臓発作と脳卒中によるものでした。そのため、心血管疾患に苦しむ人々やそれに伴う死亡者数を減らすために、核医学イメージング装置が冠動脈疾患や心臓の心筋症（心筋の疾患）などの診断に使用されています。このため、核医学イメージング装置に対する需要が急増し、予測期間（2024年～2030年）の核医学イメージング装置市場全体の成長が高まります。

さらに、核医学イメージング装置市場の成長をもたらすもう1つの主な要因は、がんの有病率の増加である可能性があります。WHO（2022）によると、がんは世界最大の死因であり、2020年の死亡者数は約1,000万人で、死亡者数のおよそ6人に1人を占めています。乳がん、肺がん、結腸がん、直腸がん、前立腺がんがもっとも頻度の高い悪性腫瘍です。上記の資料によると、毎年約40万人の子供ががんを発症しています。このように、増加するがん罹患率とそれに関連する死亡率を克服するため、核医学イメージング装置が患者の体内に広がる腫瘍を特定し、それに関連する治療法を見つけるために医師によって使用されており、このアプローチによって核医学イメージング装置への需要が増加し、予測期間（2024年～2030年）の核医学イメージング装置市場全体の急成長につながります。

しかし、核医学イメージング装置の高いコストや原子力規制委員会（NRC）による厳しい規制など、市場成長を鈍化させる一定の障壁も存在します。

進行中のCOVID-19パンデミックは、ロックダウン規制が外来受診のキャンセルや緊急性のない病院や処置の停止につながったため、核医学イメージング装置市場に影響を与えました。COVID-19患者が適切な治療を受けることが重視されたため、選択的手術は低い優先順位にありました。しかし、多くの人々が予防接種を受け、ロックダウン規制が緩和されたことで、経済が回復し経済情勢が正常に戻り、外来受診などの通常の医療サービスが再開され、核医学イメージング装置市場は勢いを取り戻し、予測期間に成長します。

核医学イメージング装置市場のセグメント分析

核医学イメージング装置市場の製品タイプセグメントでは、単一光子放出コンピューター断層撮影（SPECT）装置に比べて、陽電子放出断層撮影（PET）装置の需要が高いです。これは、PETの方がSPECTよりも新しいトレーサーの合成が容易で、より柔軟なツールであることから、PETが提供する複数の利点によるものと考えられます。さらに、PETの空間分解能は、血流を定量的に推定する能力とともに、SPECTのそれよりもかなり優れています。これは陽電子核崩壊の物理的性質によるものです。SPECTに対するPETイメージングのもっとも重要な利点は、感度が（2～3桁）大幅に優れていること、すなわち、放出されたイベントのはるかに大きな割合を検出および記録できることであり、これは大きな意味を持っています。

当レポートでは、世界の核医学イメージング装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 核医学イメージング装置市場レポートのイントロダクション

第2章 核医学イメージング装置市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 核医学イメージング装置市場の主な要因の分析

  • 核医学イメージング装置市場の促進要因
    • 心血管疾患の有病率の上昇
    • がんの罹患率の増加
    • 老年人口の増加
    • 製品提供における技術の進歩
  • 核医学イメージング装置市場の抑制要因と課題
    • 核医学イメージング装置の高いコスト
    • 原子力規制委員会（NRC）による厳しい規制
  • 核医学イメージング装置市場の機会
    • 子宮内避妊器具の研究開発活動の増加
    • AI技術への需要の高まり

第5章 核医学イメージング装置市場のポーターのファイブフォース分析

第6章 核医学イメージング装置に対するCOVID-19の影響分析

第7章 核医学イメージング装置市場のレイアウト

  • 製品タイプ別
    • 単一光子放出コンピューター断層撮影（SPECT）
    • 陽電子放出断層撮影（PET）
  • 用途別
    • 腫瘍
    • 心臓
    • 神経
    • その他
  • エンドユーザータイプ別
    • 病院
    • 画像診断センター
    • 研究センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 核医学イメージング装置市場：世界の企業シェア分析 - 主要2～3社

第9章 核医学イメージング装置市場の企業と製品のプロファイル

  • Siemens Medical Solutions USA Inc
  • General Electric Company
  • Koninklijke Philips N.V
  • DIGIRAD CORPORATION
  • Neusoft Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • SurgicEye GmbH
  • DDD-Diagnostic A/S
  • CMR Naviscan
  • Mediso Ltd
  • Shimadzu Corporation
  • MR Solutions
  • segamicorp
  • Spectrum Dynamics Medical
  • Cardinal Health
  • Curium SAS
  • BCL X-Ray Canada Inc
  • NeuroLogica Corp
  • Computerized Imaging Reference Systems Inc

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Nuclear Imaging Equipment Market in Global (2021-2030)
  • Table 4: Nuclear Imaging Equipment Market in Global by Product Type (2021-2030)
  • Table 5: Nuclear Imaging Equipment Market in Global by Application (2021-2030)
  • Table 6: Nuclear Imaging Equipment Market in Global by End User Type (2021-2030)
  • Table 7: Nuclear Imaging Equipment Market in Global by Geography (2021-2030)
  • Table 8: Nuclear Imaging Equipment Market in North America (2021-2030)
  • Table 9: Nuclear Imaging Equipment Market in North America by Country (2021-2030)
  • Table 10: Nuclear Imaging Equipment Market in the US (2021-2030)
  • Table 11: Nuclear Imaging Equipment Market in Canada (2021-2030)
  • Table 12: Nuclear Imaging Equipment Market in Mexico (2021-2030)
  • Table 13: Nuclear Imaging Equipment Market in Europe (2021-2030)
  • Table 14: Nuclear Imaging Equipment Market in Europe by Country (2021-2030)
  • Table 15: Nuclear Imaging Equipment Market in France (2021-2030)
  • Table 16: Nuclear Imaging Equipment Market in Germany (2021-2030)
  • Table 17: Nuclear Imaging Equipment Market in the United Kingdom (2021-2030)
  • Table 18: Nuclear Imaging Equipment Market in Italy (2021-2030)
  • Table 19: Nuclear Imaging Equipment Market in Spain (2021-2030)
  • Table 20: Nuclear Imaging Equipment Market in Russia (2021-2030)
  • Table 21: Nuclear Imaging Equipment Market in Rest of Europe (2021-2030)
  • Table 22: Nuclear Imaging Equipment Market in APAC (2021-2030)
  • Table 23: Nuclear Imaging Equipment Market in APAC by Country (2021-2030)
  • Table 24: Nuclear Imaging Equipment Market in China (2021-2030)
  • Table 25: Nuclear Imaging Equipment Market in Japan (2021-2030)
  • Table 26: Nuclear Imaging Equipment Market in India (2021-2030)
  • Table 27: Nuclear Imaging Equipment Market in Australia (2021-2030)
  • Table 28: Nuclear Imaging Equipment Market in South Korea (2021-2030)
  • Table 29: Nuclear Imaging Equipment Market in Rest of APAC (2021-2030)
  • Table 30: Nuclear Imaging Equipment Market in Rest of World (2021-2030)
  • Table 31: Nuclear Imaging Equipment Market in Middle East (2021-2030)
  • Table 32: Nuclear Imaging Equipment Market in Africa (2021-2030)
  • Table 33: Nuclear Imaging Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Nuclear Imaging Equipment Market in Global (2021-2030)
  • Figure 4: Nuclear Imaging Equipment Market in Global by Product Type (2021-2030)
  • Figure 5: Nuclear Imaging Equipment Market in Global by Application (2021-2030)
  • Figure 6: Nuclear Imaging Equipment Market in Global by End User Type (2021-2030)
  • Figure 7: Nuclear Imaging Equipment Market in Global by Geography (2021-2030)
  • Figure 8: Nuclear Imaging Equipment Market in North America (2021-2030)
  • Figure 9: Nuclear Imaging Equipment Market in North America by Country (2021-2030)
  • Figure 10: Nuclear Imaging Equipment Market in the US (2021-2030)
  • Figure 11: Nuclear Imaging Equipment Market in Canada (2021-2030)
  • Figure 12: Nuclear Imaging Equipment Market in Mexico (2021-2030)
  • Figure 13: Nuclear Imaging Equipment Market in Europe (2021-2030)
  • Figure 14: Nuclear Imaging Equipment Market in Europe by Country (2021-2030)
  • Figure 15: Nuclear Imaging Equipment Market in France (2021-2030)
  • Figure 16: Nuclear Imaging Equipment Market in Germany (2021-2030)
  • Figure 17: Nuclear Imaging Equipment Market in the United Kingdom (2021-2030)
  • Figure 18: Nuclear Imaging Equipment Market in Italy (2021-2030)
  • Figure 19: Nuclear Imaging Equipment Market in Spain (2021-2030)
  • Figure 20: Nuclear Imaging Equipment Market in Russia (2021-2030)
  • Figure 21: Nuclear Imaging Equipment Market in Rest of Europe (2021-2030)
  • Figure 22: Nuclear Imaging Equipment Market in APAC (2021-2030)
  • Figure 23: Nuclear Imaging Equipment Market in APAC by Country (2021-2030)
  • Figure 24: Nuclear Imaging Equipment Market in China (2021-2030)
  • Figure 25: Nuclear Imaging Equipment Market in Japan (2021-2030)
  • Figure 26: Nuclear Imaging Equipment Market in India (2021-2030)
  • Figure 27: Nuclear Imaging Equipment Market in Australia (2021-2030)
  • Figure 28: Nuclear Imaging Equipment Market in South Korea (2021-2030)
  • Figure 29: Nuclear Imaging Equipment Market in Rest of APAC (2021-2030)
  • Figure 30: Nuclear Imaging Equipment Market in Rest of World (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0228

Nuclear Imaging Equipment Market By Product Type (Single-Photon Emission Computerized Tomography (Spect), Positron Emission Tomography (Pet)), By Application (Oncology, Cardiology, Neurology And Others), By End-User (Hospitals, Diagnostic Imaging Centers, And Research Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of cardiovascular diseases and the increasing prevalence of cancers

The global Nuclear Imaging Market was valued at USD 2.57 billion in 2023, growing at a CAGR of 3.34% during the forecast period from 2024 to 2030, to reach USD 3.13 billion by 2030. The nuclear imaging equipment market is witnessing a positive growth owing to the factors such as, the rising prevalence of cardiovascular diseases, the increasing prevalence of cancers, increasing geriatric population and technological advancements in the product offerings. Thus, all these factors mentioned above are contributing to the growth of nuclear imaging equipment market during the forecast period from 2024-2030.

Nuclear Imaging Equipment Market Dynamics:

One of the main drivers of the nuclear imaging equipment market is the increasing prevalence of cardiovascular diseases. According to World Health Organization (WHO) data published in 2022, as per the latest statistics, cardiovascular diseases (CVDs) are the most common cause of mortality across the world. According to the above mentioned source, in 2019, 17.9 million people died from CVDs, accounting for 32% of all fatalities worldwide and 85% of these deaths were caused by heart attacks and strokes. Therefore, to reduce the number of people suffering with cardiovascular diseases and deaths associated with it, nuclear imaging equipment are used to diagnose coronary artery disease, cardiomyopathy in the heart (diseases of the heart muscle) and others. This will cause a surge in the demand for nuclear imaging equipment, which increases the nuclear imaging equipment overall market growth during the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the nuclear imaging equipment market can be the increasing prevalence of cancers. As per WHO 2022, cancer is the biggest cause of mortality globally, with approximately 10 million fatalities in 2020, accounting for roughly one in every six deaths. Breast, lung, colon, rectum, and prostate cancers are the most frequent malignancies. According to the above mentioned source, every year, approximately 400,000 children develop cancer. Thus, to overcome the increasing cancer rates & deaths linked with it, nuclear imaging equipment are used by doctors to identify the tumor spread in the patient's body and help to find the treatment associated with it, this approach tends to increase the demand for nuclear imaging equipment which leads to surge in the nuclear imaging equipment overall market during the forecast period (2024-2030).

However, the market will face certain barriers to growth as well, such as high cost of nuclear imaging equipment and strict regulations by the Nuclear Regulatory Commission (NRC) that can slow down the market growth.

The ongoing coronavirus pandemic has impacted the market for nuclear imaging equipment lockdown restrictions as it had led to cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. Elective surgeries were not on priority as COVID-19 patients were given more weightage pertaining to receiving adequate treatment. However, with masses being vaccinated, lockdown restriction relaxation has initiated the process of economic recovery and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits and resumption of healthcare services, allowing the nuclear imaging equipment market to pick momentum and grow in the forecast period.

Nuclear Imaging Equipment Market Segment Analysis:

Nuclear Imaging Equipment Market by Product Type (Single-Photon Emission Computerized Tomography (SPECT), Positron Emission Tomography (PET)), Application (Oncology, Cardiology, Neurology and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by-product type segment of nuclear imaging equipment market, the demand of Positron Emission Tomography (PET) is high as compared to the Single-Photon Emission Computerized Tomography (SPECT). This can be ascribed to several advantages that are offered by PET as it is a more flexible tool, because new tracers are easier to synthesize for PET than for SPECT. Furthermore, the spatial resolution, along with the capability to provide quantitative estimates of blood flow, PET is significantly superior to that of SPECT. This is owing to the physical nature of positron nuclear decay. The most significant benefit of PET imaging over SPECT is that it has a substantially better sensitivity (by two to three orders of magnitude) that is, it can detect and record a much larger percentage of the emitted events, which has major ramifications.

In November 2022, Telix Pharmaceuticals, a biopharmaceutical company, announced that the Australian Therapeutic Goods Administration (TGA) has approved Illuccix® (Kit for the preparation of 68Ga PSMA-11 Injection) is a positron emission tomography (PET) agent for the diagnostic imaging of men with prostate cancer.

Furthermore, the benefits associated with PET over SPECT, increases its demand which enhance the nuclear imaging equipment overall market during the forecast period from 2024-2030.

North America is expected to dominate the overall Nuclear Imaging Equipment Market:

Among all the regions, North America is expected to dominate the global nuclear imaging equipment market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. Factors such as the rising prevalence of cardiovascular diseases and technological advancements in the product offerings will drive the use of nuclear imaging equipment which increases the demand of nuclear imaging equipment in the North America market.

According to the Centers for Disease Control and Prevention (CDC) 2022, in the United States, as per the latest statistics, one person dies from cardiovascular disease in every 36 seconds. According to the above mentioned source, heart disease claim the lives of around 659,000 people in the United States each year, accounting for one out of every four fatalities. As per CDC, the most frequent kind of heart illness, coronary heart disease had killed 360,900 people in the year 2019. Furthermore, it had affected about 18.2 million people aged 20 and above (about 6.7%). Therefore, in order to treat the number of people suffering from cardiovascular diseases and to reduce the number of deaths related to it, nuclear imaging equipment are used to evaluate coronary artery disease, cardiomyopathy in the heart (diseases of the heart muscle) and others, this has further led to an increase in the demand of nuclear imaging equipment, which would surge the nuclear imaging equipment overall market during the forecast period (2024-2030).

Furthermore, another factor such as the technological advancements in the nuclear imaging equipment such as, in March 2022, at RSNA 2022, Philips, a health-tech company, highlighted the launch of two new cutting-edge CT systems: the multi-energy Spectral CT 7500 and the CT 5100 Incisive with integrated artificial intelligence.

Apart from this, in March 2022, NeuroLogica Corp, a Samsung Electronics Co. Ltd. subsidiary, announced that its state-of-the-art OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology. The company introduces the first single-source photon counting computed tomography (CT) scanner with single detector on a transportable device. OmniTom Elite with PCD is capable of producing spectral CT pictures at various energy levels. Therefore, such technological advancements in the nuclear imaging equipment, can increase the demand for nuclear imaging equipment, which could drive the nuclear imaging equipment overall market growth.

Therefore, due to interplay of the factors mentioned above, the demand for nuclear imaging equipment could boost, which in turn would provide a conducive growth environment in North American region for the nuclear imaging equipment during market forecast 2024-2030.

Nuclear Imaging Equipment Market Key Players:

Some of the key market players operating in the nuclear imaging equipment market include Siemens Medical Solutions USA Inc, General Electric Company, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd, Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc, NeuroLogica Corp, Computerized Imaging Reference Systems, Inc, and among others.

Recent Developmental Activities in the Nuclear Imaging Equipment:

  • In May 2022, Mediso Ltd, a Hungarian manufacturer of nuclear medicine imaging equipment, announced the acquisition of Bartec Technologies Ltd, UK based company specialized in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories.
  • In December 2022, Computerized Imaging Reference Systems, Inc., a leading provider of medical imaging and radiation therapy phantoms serving the medical industry, has been acquired by Mirion Technologies, Inc., a global provider of detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets.
  • In April 2020, TTG Imaging Solutions, LLC, announced that it has acquired Nuclear Imaging Services and its Texas-based radiopharmacy. The company also announced it had acquired Molecular Imaging Specialists, a medical imaging equipment and service provider in Ft. Lauderdale.

Key Takeaways from the Nuclear Imaging Equipment Market Report Study

  • Market size analysis for current nuclear imaging equipment market size (2023), and market forecast for 5 years (2024-2030).
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Nuclear imaging equipment.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened for last 3 years.
  • Key companies dominating the global nuclear imaging equipment.
  • Various opportunities are available for the other competitor in the Nuclear imaging equipment Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current nuclear imaging equipment Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Nuclear imaging equipment Market growth in the coming future?

Target Audience who can be benefited from this Nuclear Imaging Equipment Market Report Study

  • Nuclear imaging equipment products providers
  • Research organizations and consulting companies
  • Nuclear imaging equipment-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in nuclear imaging equipment
  • Various End-users who want to know more about the nuclear imaging equipment Market and latest technological developments in the nuclear imaging equipment.

Frequently Asked Questions for Nuclear Imaging Equipment:

1. What are Nuclear Imaging Equipment?

A unique gamma camera and single-photon emission computed tomography (SPECT) imaging methods are used in nuclear medicine. The gamma camera captures and transforms the energy emitted by the radiotracer in the body into a picture.

2. What is the market for Global Nuclear Imaging Equipment?

The global nuclear imaging equipment Market was valued at USD 2.57 billion in 2023, growing at a CAGR of 3.34% during the forecast period from 2024 to 2030 to reach USD 3.13 billion by 2030.

3. What are the drivers for the Global Nuclear Imaging Equipment Market?

The nuclear imaging equipment market is witnessing a positive market growth owing to the factors such as, the rising prevalence of cardiovascular diseases, the increasing prevalence of cancers, increasing geriatric population and technological advancements in the product offerings

4. Who are the key players operating in the Nuclear Imaging Equipment Market?

Some of the key market players operating in the nuclear imaging equipment market include Siemens Medical Solutions USA Inc, General Electric Company, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd, Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc, NeuroLogica Corp, Computerized Imaging Reference Systems, Inc, and among others.

5. Which region has the highest share in Nuclear Imaging Equipment Market?

North America is expected to dominate the global nuclear imaging equipment market. Factors contributing to the growth are the rising prevalence of cardiovascular diseases and technological advancements in the product offerings drives the nuclear imaging equipment market growth in this region.

Table of Contents

1.Nuclear Imaging Equipment Market Report Introduction

2.Nuclear Imaging Equipment Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Nuclear Imaging Equipment Market Key Factors Analysis

  • 4.1. Nuclear Imaging Equipment Market Drivers
    • 4.1.1. The Rising Prevalence of Cardiovascular Diseases
    • 4.1.2. The Increasing Prevalence of Cancers
    • 4.1.3. Increasing Geriatric Population
    • 4.1.4. Technological Advancements in the Product Offerings
  • 4.2. Nuclear Imaging Equipment Market Restraints And Challenges
    • 4.2.1. High Cost of Nuclear Imaging Equipment
    • 4.2.2. Strict Regulations by the Nuclear Regulatory Commission (NRC)
  • 4.3. Nuclear Imaging Equipment Market Opportunities
    • 4.3.1. Increasing Research and Development Activities in Intrauterine Devices
    • 4.3.2. Growing Demand for the Artificial Intelligence Technology

5. Nuclear Imaging Equipment Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Nuclear Imaging Equipment

7. Nuclear Imaging Equipment Market Layout

  • 7.1. By Product Type
    • 7.1.1. Single-Photon Emission Computerized Tomography (SPECT)
    • 7.1.2. Positron Emission Tomography (PET)
  • 7.2. By Application
    • 7.2.1. Oncology
    • 7.2.2. Cardiology
    • 7.2.3. Neurology
    • 7.2.4. Others
  • 7.3. By End User Type
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Imaging Centers
    • 7.3.3. Research Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Nuclear Imaging Equipment Market, by Country
      • 7.4.1.1.1. US
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Nuclear Imaging Equipment Market, by Country
      • 7.4.2.1.1. France
      • 7.4.2.1.2. Germany
      • 7.4.2.1.3. United Kingdom
      • 7.4.2.1.4. Italy
      • 7.4.2.1.5. Spain
      • 7.4.2.1.6. Russia
      • 7.4.2.1.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Nuclear Imaging Equipment Market, by Country
      • 7.4.3.1.1. China
      • 7.4.3.1.2. Japan
      • 7.4.3.1.3. India
      • 7.4.3.1.4. Australia
      • 7.4.3.1.5. South Korea
      • 7.4.3.1.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Intrauterine Devices Market, by Region
      • 7.3.4.1.1. Middle East
      • 7.3.4.1.2. Africa
      • 7.3.4.1.3. South America

8. Nuclear Imaging Equipment Market Global Company Share Analysis - Key 2-3 Companies

9. Nuclear Imaging Equipment Market Company and Product Profiles

  • 9.1. Siemens Medical Solutions USA Inc
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. General Electric Company
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Koninklijke Philips N.V
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. DIGIRAD CORPORATION
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Neusoft Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. CANON MEDICAL SYSTEMS CORPORATION
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. SurgicEye GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. DDD-Diagnostic A/S
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. CMR Naviscan
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Mediso Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Shimadzu Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. MR Solutions
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. segamicorp
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Spectrum Dynamics Medical
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Cardinal Health
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Curium SAS
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. BCL X-Ray Canada Inc
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. NeuroLogica Corp
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Computerized Imaging Reference Systems Inc
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us